Table 2.
Item | Number of studies | Sample size | Diabetes | Prevalence(95%CI, %) | I2 |
P values |
|
Heterogeneity | Subgroup difference | ||||||
Overall | 23 | 49564 | 1573 | 10 (7-15) | 97% | < 0.01 | - |
Subgroup analysis | |||||||
Sample size | 0.002 | ||||||
≤ 100 | 10 | 574 | 55 | 9 (6-11) | 28% | 0.14 | |
100-200 | 8 | 1252 | 178 | 14 (11-16) | 60% | 0.02 | |
> 200 | 5 | 49588 | 1340 | 7 (4-9) | 94% | < 0.0001 | |
Location | < 0.0001 | ||||||
Wuhan, China | 13 | 1556 | 222 | 14 (12-16) | 35% | 0.12 | |
Outside of Wuhan, China | 8 | 1746 | 119 | 7 (6-8) | 0% | 0.79 | |
China (all cities) | 2 | 46262 | 1432 | 5 (0-11) | 99% | < 0.0001 | |
Age group | < 0.0001 | ||||||
≤ 50 yr | 10 | 3358 | 257 | 7 (6-8) | 10% | 0.27 | |
> 50 yr | 12 | 1534 | 214 | 13 (11-16) | 45% | 0.05 | |
ICU admission | 0.94 | ||||||
ICU | 2 | 112 | 20 | 15 (4-26) | 47% | 0.17 | |
Non-ICU | 2 | 1519 | 118 | 14 (3-35) | 78% | 0.03 | |
Severity | < 0.0001 | ||||||
Severe | 8 | 553 | 99 | 17 (14-20) | 0% | 0.92 | |
Non-severe | 7 | 2190 | 143 | 6 (5-8) | 41% | 0.05 | |
Death | 0.02 | ||||||
Death | 5 | 1146 | 120 | 30 (13-46) | 89% | < 0.0001 | |
Survival | 5 | 45508 | 1191 | 8 (2-15) | 99% | < 0.0001 |
ICU: Intensive care unit.